Biomarkers in Overactive Bladder: A New Objective and Noninvasive Tool?

被引：43

作者：

Antunes-Lopes, Tiago ^{[1
,2
,3
]}

Carvalho-Barros, Sergio ^{[3
]}

Cruz, Celia-Duarte ^{[3
,4
]}

Cruz, Francisco ^{[1
,2
,3
,4
]}

Martins-Silva, Carlos ^{[1
,2
,3
]}

机构：

[1] Hosp De S Joao, Dept Urol, P-4200319 Oporto, Portugal

[2] Univ Porto, Fac Med, P-4200319 Oporto, Portugal

[3] Univ Porto, IBMC, P-4150180 Oporto, Portugal

[4] Univ Porto, Fac Med, Inst Histol & Embryol, P-4200319 Oporto, Portugal

来源：

ADVANCES IN UROLOGY | 2011年 / 2011卷

关键词：

D O I：

10.1155/2011/382431

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Overactive bladder syndrome (OAB) is a highly prevalent urinary dysfunction, with considerable economic and human costs. Clinical diagnosis of OAB is still based on subjective symptoms. A new accurate, objective and noninvasive test to diagnose OAB and assess therapeutic outcome is lacking. Recent studies in lower urinary tract (LUT) dysfunctions, particularly in OAB patients, indicate that urinary proteins (neurotrophins, prostaglandins, and cytokines), serum C reactive protein, and detrusor wall thickness are altered, and such changes could be used as biomarkers of the disease. Nowadays, increasing emphasis has been given to the role of urinary neurotrophins, namely nerve growth factor (NGF) and brain derived neurotrophic factor ( BDNF), as key players in some urinary dysfunctions. Although recently considered to be a bladder dysfunction biomarker, urinary NGF presents low sensitivity and specificity. Preliminary results suggest that BDNF may serve as a more efficient biomarker. Even though we have to wait for future studies to confirm the potential role of NGF and BDNF as OAB biomarkers, it is already clear that neurotrophins will contribute to elucidate the physiopathological basis of OAB. Herein are reviewed the latest advances in this new and exciting field, the detection and clinical application of emerging OAB biomarkers.

引用

页数：7

共 72 条

[41]

Chen C.Y., Kuo H.C., Novel urinary biomarkers in the diagnosis and assessment of overactive bladder, Incontinence and Pelvic Floor Dysfunction, 3, 1, pp. 20-23, (2009)

[42]

Antunes-Lopes T., Urinary neurotrophinspotential biomarkers of overactive bladder, Journal of Urology, 185, 4 S, pp. 780-781, (2011)

[43]

Birder L.A., Wolf-Johnston A., Griffiths D., Resnick N.M., Role of urothelial nerve growth factor in human bladder function, Neurourology and Urodynamics, 26, 3, pp. 405-409, (2007)

[44]

Liu H.T., Kuo H.C., Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment, Urology, 72, 1, pp. 104-108, (2008)

[45]

Liu H.T., Chancellor M.B., Kuo H.C., Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder, British Journal of Urology International, 103, 12, pp. 1668-1672, (2009)

[46]

Liu H.T., Chancellor M.B., Kuo H.C., Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection, European Urology, 56, 4, pp. 700-707, (2009)

[47]

Pezet S., Malcangio M., McMahon S.B., BDNF: A neuromodulator in nociceptive pathways?, Brain Research Reviews, 40, 1-3, pp. 240-249, (2002)

[48]

Kerr B.J., Bradbury E.J., Bennett D.L.H., Trivedi P.M., Dassan P., French J., Shelton D.B., McMahon S.B., Thompson S.W.N., Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord, Journal of Neuroscience, 19, 12, pp. 5138-5148, (1999)

[49]

Merighi A., Salio C., Ghirri A., Lossi L., Ferrini F., Betelli C., Bardoni R., BDNF as a pain modulator, Progress in Neurobiology, 85, 3, pp. 297-317, (2008)

[50]

Michael G.J., Averill S., Nitkunan A., Rattray M., Bennett D.L.H., Van Q., Priestley J.V., Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord, Journal of Neuroscience, 17, 21, pp. 8476-8490, (1997)

← 1 2 3 4 5 6 7 8 →